Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates
about
Current and emerging azole antifungal agentsPlasticity of Candida albicans BiofilmsIn vitro susceptibility testing methods for caspofungin against Aspergillus and Fusarium isolatesEvaluation of Etest method for determining posaconazole MICs for 314 clinical isolates of Candida speciesEpidemiology of invasive candidiasis: a persistent public health problemInternational surveillance of bloodstream infections due to Candida species: frequency of occurrence and in vitro susceptibilities to fluconazole, ravuconazole, and voriconazole of isolates collected from 1997 through 1999 in the SENTRY antimicrobiaActivities of available and investigational antifungal agents against rhodotorula speciesDetection of resistance to amphotericin B among Cryptococcus neoformans clinical isolates: performances of three different media assessed by using E-test and National Committee for Clinical Laboratory Standards M27-A methodologiesEvaluation of the Etest method for determining fluconazole susceptibilities of 402 clinical yeast isolates by using three different agar media.Stable phenotypic resistance of Candida species to amphotericin B conferred by preexposure to subinhibitory levels of azoles.Optimizing the correlation between results of testing in vitro and therapeutic outcome in vivo for fluconazole by testing critical isolates in a murine model of invasive candidiasisIn vitro activity of a new polyene, SPA-S-843, against yeasts.Collaborative study of antibiotic medium 3 and flow cytometry for identification of amphotericin B-resistant Candida isolates.Aspergillus infections in transplant recipients.Practice guidelines for the treatment of candidiasis. Infectious Diseases Society of America.In vitro susceptibilities of Candida dubliniensis isolates tested against the new triazole and echinocandin antifungal agents.Comparison of E-test and broth microdilution methods for antifungal drug susceptibility testing of moldsDisk diffusion method for determining susceptibilities of Candida spp. to MK-0991.Optimizing voriconazole susceptibility testing of Candida: effects of incubation time, endpoint rule, species of Candida, and level of fluconazole susceptibility.Quantitation of ergosterol content: novel method for determination of fluconazole susceptibility of Candida albicansIn vitro susceptibility testing of filamentous fungi: comparison of Etest and reference microdilution methods for determining itraconazole MICsEvaluation of the Etest method for determining voriconazole susceptibilities of 312 clinical isolates of Candida species by using three different agar mediaImproved detection of amphotericin B-resistant isolates of Candida lusitaniae by EtestComparison of the E-test with the NCCLS M38-P method for antifungal susceptibility testing of common and emerging pathogenic filamentous fungi.Trends in antifungal susceptibility among Swedish Candida species bloodstream isolates from 1994 to 1998: comparison of the E-test and the Sensititre YeastOne Colorimetric Antifungal Panel with the NCCLS M27-A reference method.Evaluation of Etest method for determining caspofungin (MK-0991) susceptibilities of 726 clinical isolates of Candida species.Antifungal susceptibility testing: practical aspects and current challenges.Correlation between in vitro susceptibility determined by E test and response to therapy with amphotericin B: results from a multicenter prospective study of candidemia.Detection of resistance to amphotericin B in Candida isolates by using Iso-Sensitest broth.Rates and extents of antifungal activities of amphotericin B, flucytosine, fluconazole, and voriconazole against Candida lusitaniae determined by microdilution, Etest, and time-kill methods.In vitro activities of ravuconazole and voriconazole compared with those of four approved systemic antifungal agents against 6,970 clinical isolates of Candida spp.Effect of the echinocandin caspofungin on expression of Candida albicans secretory aspartyl proteinases and phospholipase in vitroE-test method for testing susceptibilities of Aspergillus spp. to the new triazoles voriconazole and posaconazole and to established antifungal agents: comparison with NCCLS broth microdilution method.In vitro antifungal susceptibility testing.In vitro activity of nystatin compared with those of liposomal nystatin, amphotericin B, and fluconazole against clinical Candida isolatesEvaluation of amphotericin B interpretive breakpoints for Candida bloodstream isolates by correlation with therapeutic outcomeIn vitro activities of voriconazole, posaconazole, and four licensed systemic antifungal agents against Candida species infrequently isolated from blood.Flucytosine-fluconazole cross-resistance in purine-cytosine permease-deficient Candida lusitaniae clinical isolates: indirect evidence of a fluconazole uptake transporterHas antifungal susceptibility testing come of age?Correlation between E-test, disk diffusion, and microdilution methods for antifungal susceptibility testing of fluconazole and voriconazole
P2860
Q24550733-C855F93E-56E8-4FE8-A137-27EDF3296BDDQ26744150-0733C538-6C62-43EE-A2A8-44DB91E61A2DQ28345261-667B5DA3-FD32-4162-971C-C46729153DC7Q28362760-DE4F868D-1735-48D9-8931-0E2BFD4F0535Q29616758-1BD884B7-D098-4535-85EB-63D7B878A214Q30453797-C6C673AC-2A81-4036-8059-DDAEEA927F08Q33210616-42405B00-AA4D-4D37-88FD-F17E462C283BQ33677651-16BA8607-A375-4074-8BA5-F905FE81A23CQ33682433-5B7DC89F-2A80-44E1-83F3-0C8A3C17C4ABQ33683250-07576DD8-DB32-41CF-88B9-D6D051FD9D82Q33690616-E9600162-6669-4BB5-A7A4-229488A8905FQ33702041-0BCF4E76-B55C-4BE8-9159-E73517F43FBAQ33714825-C06805A2-1013-482D-9017-044CAFCB2CDAQ33719294-4B718DB7-8299-4F80-931F-6470BB9C6089Q33894467-9FE98A99-E513-4705-B517-77F031881A17Q33959506-5AD5949D-66C5-47B0-892F-7BC57FA08806Q33960284-0EE40F5E-8E23-4189-AE7B-09AFC6C2A405Q33960454-1174E091-42AB-4142-B9D0-30C0740947B7Q33962343-647A78CB-3FC5-4606-957A-E9CAFCB78A4FQ33963057-4B6DD5F2-B93F-4708-A4C8-F4A9D8BEE651Q33969644-CB989222-0740-4F78-BA97-C52658D593A9Q33969963-E4EC606A-28E6-4FCA-B3C3-67D3B56FE619Q33971002-2531FF32-73CC-4E7A-B1DC-1675DBED92C0Q33971884-F2517CCC-2346-4866-8660-215627D3D70CQ33974143-531A0B86-068C-4378-B233-92DD51C2280BQ33974286-287F5B26-FE36-43D7-9521-B5A7E6EC7420Q33975757-7325EB81-9EAC-426B-BEAA-F398AF2ACB26Q33976842-5A54EB40-E22C-4F49-9560-1346A47CBC16Q33982529-EB2ABE0C-3CD6-4D1D-A945-0DF2A2ED316CQ34105231-2B6A1A18-D5AF-437B-865E-E6923E992EA2Q34109559-B772D37D-78DE-4E5B-8F36-F7E0D961889EQ34112321-297D899B-1A81-4D2B-A560-BC8D50B437B7Q34193850-85636D94-5889-4A09-8462-67C579476137Q34335217-FE056934-E5C5-4977-BD64-B80879C1028FQ34452652-458781BF-06DB-41CA-8C62-2F55B7A307B5Q34510359-20512D21-C732-461E-8A72-FFBB3EA0E6C6Q34749162-25F9F9D3-7CFD-4C4C-9EAE-4B67A4E9D20FQ34883912-09BA90BE-9F7D-4809-ABD9-3FA48CDA61DAQ34923038-B645589A-9807-4AEC-9E52-A5D7C3495074Q34941412-13CADC42-18F5-484E-87F1-CFC765138D86
P2860
Comparison of Etest and National Committee for Clinical Laboratory Standards broth macrodilution method for antifungal susceptibility testing: enhanced ability to detect amphotericin B-resistant Candida isolates
description
1995 nî lūn-bûn
@nan
1995 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Comparison of Etest and Nation ...... n B-resistant Candida isolates
@ast
Comparison of Etest and Nation ...... n B-resistant Candida isolates
@en
type
label
Comparison of Etest and Nation ...... n B-resistant Candida isolates
@ast
Comparison of Etest and Nation ...... n B-resistant Candida isolates
@en
prefLabel
Comparison of Etest and Nation ...... n B-resistant Candida isolates
@ast
Comparison of Etest and Nation ...... n B-resistant Candida isolates
@en
P2093
P2860
P356
P1476
Comparison of Etest and Nation ...... n B-resistant Candida isolates
@en
P2093
P2860
P304
P356
10.1128/AAC.39.11.2520
P407
P577
1995-11-01T00:00:00Z